remifentanil-PCA
…ession requiring mask ventilation or intubation associated with remifentanil-PCA usage. This positive safety record can be attributed to our wel…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 29 of 2459University of GenoaCochranePrimary angle closure glaucomaPACSglaucomaMitomycinUniversity of GenovaUCL
… generously shared their lived experiences, and the team at the University of Genoa, who worked tirelessly to refine content and layout, ensuring c…
ankyloglossia
…t differ between eligible and included dyads. The prevalence of ankyloglossia (scores 0–3) was 3.5% (95% CI 2.5–4.9), rising to 18.3% (95% CI…
Carvedilol
…red intervention (banding and/or sclerotherapy )before starting Carvedilol. Screening before commencing Carvedilol, dose of Carvedilol and…
OdevixibatPFICALGSLiquigenHeparon JuniorAlagille syndrome
…patocellular damage potentially requiring a liver transplant. 1 Odevixibat, an oral inhibitor of the ileal bile acid transporter, is being…
E-272 Tenecteplase versus alteplase for acute ischemic stroke: a propensity matched TriNetX Analysis
alteplaseclopidogrelTNKwarfarinTenecteplase
… lower mortality at 6 months, 1 year, and 3 years compared with alteplase, without increased intracerebral hemorrhage. Early cognitive im…
DiarrhoeadiarrhoealPubMedDysbiosisWeb of Science
…Diarrhoea remains an important cause of morbidity and mortality among chi…
99.0%
colorectal cancerCRC5-fluorouracilITGBL1
…te the impact of ITGBL1 on 5-fluorouracil (5-FU) sensitivity in colorectal cancer and explore its underlying molecular mechanisms.Methods ITGBL1 …
H. pyloriminocyclineHelicobacter pyloridoxycyclineclarithromycinfurazolidoneCLA-BQTFUR-BQTDOX-BQTMIN-BQT+1 more
…a multivariable logistic regression.Results For treatment-naive H. pylori infections, the combined BQT regimens achieved a significantly …
Royal Blackburn HospitalISRin-stent restenosisacute coronary syndromede novo coronary lesions
…hods and Results Methods: We conducted a retrospective study at Royal Blackburn Hospital, involving 117 patients who underwent drug-coated balloon (DCB)…
SLEleucopeniabelimumabBELlymphopeniaanaemia
…, thrombocytopenia, lymphopenia and leucopenia in patients with SLE.Methods The BeRLiSS (Belimumab in Real Life Setting Study) 2.0 …